Solmaz Shirjang

7PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer cell biologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2020
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1.

Solmaz Shirjang, Behzad Mansoori, Ali Mohammadi

|Mar 17, 2020
Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness.

Behzad Mansoori, Pascal H G Duijf, Ali Mohammadi

|Jan 29, 2020
Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.

Behzad Mansoori, Ali Mohammadi, Fereydoon Abedi-Gaballu

|Mar 03, 2019
HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancy.

Behzad Mansoori, Ali Mohammadi, Zahra Asadzadeh

|Feb 12, 2019
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancer.

Behzad Mansoori, Ali Mohammadi, Morten F Gjerstorff

|Dec 18, 2018
Promising immunotherapy: Highlighting cytokine-induced killer cells.

Solmaz Shirjang, Nazila Alizadeh, Behzad Mansoori

Pageof 2

Frequent Collaborators

5 joint publications

Behzad Mansoori

5 joint publications

Behzad Baradaran

4 joint publications

Ali Mohammadi

3 joint publications

Tohid Kazemi